Bluebird Bio (NQ: BLUE )
0.5615
-0.0309
(-5.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Headline News about Bluebird Bio
What 4 Analyst Ratings Have To Say About bluebird bio
January 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/23/image-skechers.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/716946/moonlake.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/18/shutterstock_1005701752.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/18/image21_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/18/25.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/711617/patient-sitting-on-hospital-bed.jpg)
![](https://investorplace.com/wp-content/uploads/2021/01/veterinarian-zom-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/mrna_moderna1600.png)
![](https://g.foolcdn.com/editorial/images/716976/vaccine-gettyimages-1298099807.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 18, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
Looking Into bluebird bio's Return On Capital Employed
November 30, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7192.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/715245/patient-talking-with-a-physician.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/05/pill-_image_by_arek_socha_from_pixabay_.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/714458/investors-watch-a-presentation-around-a-table.jpg)
![](https://g.foolcdn.com/editorial/images/713791/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/19/blue_logo_light__1624b39f83a9fa5bb91803f2d607e59a.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/blue-1600.png)
![](https://cdn.benzinga.com/files/images/story/2022/12/13/magenta-logo-color-png.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/712778/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg)
![](https://public.newsdirect.com/921481264/9k3wzirG.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/blue_logo_light__1624b39f83a9fa5bb91803f2d607e59a.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/23/77d555b1-6d49-48f7-8f99-67954a7a9e69.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/709891/physician-shaking-patients-hand.jpg)
![](https://g.foolcdn.com/editorial/images/709470/patient-sitting-on-hospital-bed.jpg)
2 Growth Stocks That Could Double in 2023
November 17, 2022
Via The Motley Fool
![](https://cdn.benzinga.com/files/images/story/2022/11/08/image16.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.